EUMCA News 

Who would benefit from the legalisation of medical cannabis? Schubert says “chronic pain patients benefit from medical cannabis." “It could be the most disruptive change in the pharmaceutical industry for a long time. We would be able to switch patients from opiates...

BOGOTÁ, Colombia, June 04, 2020 (GLOBE NEWSWIRE) -- Clever Leaves (the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has been granted Good Agricultural and Collecting Practices...

"We are super glad to announce that Cannaflos received its pharmaceutical wholesale distribution authorization and has already started operations by importing and providing medical cannabis products to German patients." "We are looking forward to helping shape the...

Certification signals another milestone for EU campus as Tilray’s international medical cannabis hubLicensing expands company’s international export capacity to serve authorized medical cannabis markets Provides authorization to complete medical cannabis extraction...

"The latest data that came from a UK organisation, the CMC, involved analyzing 30 different products.. Only 38% of them had ingredients close to what was claimed on the label. In fact, one product had no cannabinoid in it at all." "To my mind, this whole area needs...

The court’s opinion could go beyond e-cigarettes, according to Sita Schubert, General Secretary of the newly-born European Medicinal Cannabis Association (EUMCA), because “it clearly underlines that there shall be an alignment for introducing CBD products to the...